
Tetrahedron p. 11619 - 11639 (1999)
Update date:2022-08-04
Topics:
Siegel, Miles G.
Chaney, Michael O.
Bruns, Robert F.
Clay, Michael P.
Schober, Douglas A.
Van Abbema, Anne M.
Johnson, Douglas W.
Cantrell, Buddy E.
Hahn, Patric J.
Hunden, David C.
Gehlert, Donald R.
Zarrinmayeh, Hamideh
Ornstein, Paul L.
Zimmerman, Dennis M.
Koppel, Gary A.
This study describes the integrated application of parallel synthesis and computational chemistry to the design of potent nonpeptide antagonists for the neuropeptide Y-1 (NPY1) receptor. A lead molecule was modeled in the active site of the NPY1 receptor, and a potentially fruitful region for analog construction was identified. Synthesis of suitable scaffolds followed by solution phase generation of a small library of analogs produced a compound with 5-fold improvement in binding over the already potent lead. This new compound was shown to be an unanticipated side product of the parallel synthesis reaction.
View MoreSHENYANG COMEBOARD TECHNOLOGY CO., LTD
Contact:+86-24-25724626
Address:Room2210,Tianbao International Building,No.8-1 Weigong South Street,Tiexi District,Shenyang,China
Shandong united-rising pharmaceutical cooperation.,ltd.
Contact:008653187965009
Address:171No., Jing5 Road, Shizhong District, Jinan, China
TIANJIN DONGRUXIANG MINERALS MARKETING CO.,LTD(expird)
Contact:22-58516360
Address:tianjin
Chengdu Boon Stream Chemical Industry Co.,Ltd.
Contact:+86-28-83156758
Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
Qingdao Kingway Pharmtech Co., Ltd.
Contact:86-532-87118899
Address:No. 88, Middle Haixi Road, Jiaonan City, Qingdao, China
Doi:10.1021/jo01258a002
(1969)Doi:10.1021/jo981950u
(1999)Doi:10.1021/jo050680u
(2005)Doi:10.1021/jm100459k
(2010)Doi:10.1016/S0040-4039(97)01428-7
(1997)Doi:10.1021/om970378e
(1997)